Sagent Pharmaceuticals Announces the Launch of Flumazenil Injection, USP

[at noodls] – SCHAUMBURG, Ill., Jan. 2, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced the … more

View todays social media effects on SGNT

View the latest stocks trending across Twitter. Click to view dashboard

See who Sagent is hiring next, click here to view